Built to transform aerospace power, FAERO™ is designed for long-range, high-speed missions with up to 80% higher energy density and 4X the energy at full power compared with today’s high-power lithium ...
Recursion announces FDA alignment for REC-4881’s Phase 3 trial in familial adenomatous polyposis, targeting crucial adenoma excision outcomes.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
Malicious JavaScript loading through a third-party script layer on November 16, exposing visitors to potential cryptocurrency ...
Claude calling Anthropic's S-1 insightful is zero surprise. Like it was ever going to call its own maker's filing boring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results